451 related articles for article (PubMed ID: 19387080)
1. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor.
Okumura N; Ueno M; Koizumi N; Sakamoto Y; Hirata K; Hamuro J; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3680-7. PubMed ID: 19387080
[TBL] [Abstract][Full Text] [Related]
2. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue.
Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Tsuchiya H; Hamuro J; Kinoshita S
Am J Pathol; 2012 Jul; 181(1):268-77. PubMed ID: 22704232
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing.
Okumura N; Nakano S; Kay EP; Numata R; Ota A; Sowa Y; Sakai T; Ueno M; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):318-29. PubMed ID: 24106120
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle kinetics in corneal endothelium from old and young donors.
Senoo T; Joyce NC
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):660-7. PubMed ID: 10711678
[TBL] [Abstract][Full Text] [Related]
5. Rho-associated protein kinase inhibitor, Y-27632, significantly enhances cell adhesion and induces a delay in G1 to S phase transition in rabbit corneal endothelial cells.
Diao YM; Hong J
Mol Med Rep; 2015 Aug; 12(2):1951-6. PubMed ID: 25891854
[TBL] [Abstract][Full Text] [Related]
6. The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction.
Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hamuro J; Kinoshita S
Cornea; 2011 Oct; 30 Suppl 1():S54-9. PubMed ID: 21912232
[TBL] [Abstract][Full Text] [Related]
7. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression.
Chen J; Guerriero E; Lathrop K; SundarRaj N
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):175-83. PubMed ID: 18172090
[TBL] [Abstract][Full Text] [Related]
8. Cultivated corneal endothelial cell sheet transplantation in a primate model.
Koizumi N; Sakamoto Y; Okumura N; Okahara N; Tsuchiya H; Torii R; Cooper LJ; Ban Y; Tanioka H; Kinoshita S
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4519-26. PubMed ID: 17898273
[TBL] [Abstract][Full Text] [Related]
9. Effect of Rho-associated kinase inhibitor on human corneal endothelial cell apoptosis.
Achiron A; Feldman A; Karmona L; Peʼer L; Avizemer H; Bartov E; Burgansky Z; Rosner M; Vishnevskia-Dai V
J Cataract Refract Surg; 2020 Apr; 46(4):612-616. PubMed ID: 32079844
[TBL] [Abstract][Full Text] [Related]
10. Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells.
Heng BC
Tissue Cell; 2009 Oct; 41(5):376-80. PubMed ID: 19261317
[TBL] [Abstract][Full Text] [Related]
11. The stimulatory effect of ROCK inhibitor on bovine corneal endothelial cells.
Li S; Wang C; Dai Y; Yang Y; Pan H; Zhong J; Chen J
Tissue Cell; 2013 Dec; 45(6):387-96. PubMed ID: 23909974
[TBL] [Abstract][Full Text] [Related]
12. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing.
Okumura N; Koizumi N; Kay EP; Ueno M; Sakamoto Y; Nakamura S; Hamuro J; Kinoshita S
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2493-502. PubMed ID: 23462749
[TBL] [Abstract][Full Text] [Related]
13. Y-27632, a ROCK Inhibitor, Promoted Limbal Epithelial Cell Proliferation and Corneal Wound Healing.
Sun CC; Chiu HT; Lin YF; Lee KY; Pang JH
PLoS One; 2015; 10(12):e0144571. PubMed ID: 26673160
[TBL] [Abstract][Full Text] [Related]
14. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
15. ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells.
Lingor P; Tönges L; Pieper N; Bermel C; Barski E; Planchamp V; Bähr M
Brain; 2008 Jan; 131(Pt 1):250-63. PubMed ID: 18063589
[TBL] [Abstract][Full Text] [Related]
16. Stimulatory effect of Rho-associated coiled-coil kinase (ROCK) inhibitor on revivability of in vitro-produced bovine blastocysts after vitrification.
Hochi S; Abdalla H; Hara H; Shimoda M; Morita H; Kuwayama M; Hirabayashi M
Theriogenology; 2010 May; 73(8):1139-45. PubMed ID: 20171722
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic exposure of human corneal endothelial cells to Rho-associated kinase inhibitor reduced apoptosis rate after phacoemulsification: Ex vivo study.
Achiron A; Feldman A; Karmona L; Avizemer H; Barequet IS; Rosner M; Knyazer B; Bartov E; Burgansky Z; Vishnevskia-Dai V
J Cataract Refract Surg; 2018 Oct; 44(10):1261-1266. PubMed ID: 30172567
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops.
Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hirata K; Torii R; Hamuro J; Kinoshita S
Br J Ophthalmol; 2011 Jul; 95(7):1006-9. PubMed ID: 21398412
[TBL] [Abstract][Full Text] [Related]
19. ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells.
Li X; Krawetz R; Liu S; Meng G; Rancourt DE
Hum Reprod; 2009 Mar; 24(3):580-9. PubMed ID: 19056770
[TBL] [Abstract][Full Text] [Related]
20. Rho-associated kinase inhibitor Y-27632 promotes survival of cynomolgus monkey embryonic stem cells.
Takehara T; Teramura T; Onodera Y; Kakegawa R; Fukunaga N; Takenoshita M; Sagawa N; Fukuda K; Hosoi Y
Mol Hum Reprod; 2008 Nov; 14(11):627-34. PubMed ID: 18940855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
